Apyx Medical Corp - Common Stock (APYX) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2018 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
APYX on Nasdaq
Shares outstanding
41,168,218
Price per share
$3.99
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
19,029,797
Total reported value
$66,600,441
% of total 13F portfolios
0%
Share change
+3,292,746
Value change
+$11,936,562
Number of holders
58
Price from insider filings
$3.99
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Apyx Medical Corp - Common Stock (APYX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nantahala Capital Management, LLC 10% 0% $14,394,468 +$2,168,145 4,112,705 +18% Nantahala Capital Management, LLC 31 Dec 2025
ROYCE & ASSOCIATES LP 6% $8,550,622 2,443,035 ROYCE & ASSOCIATES LP 31 Dec 2025

As of 31 Dec 2025, 58 institutional investors reported holding 19,029,797 shares of Apyx Medical Corp - Common Stock (APYX). This represents 46% of the company’s total 41,168,218 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Apyx Medical Corp - Common Stock (APYX) together control 44% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Nantahala Capital Management, LLC 9.7% 3,974,091 +19% 0.83% $13,909,318
Archon Capital Management LLC 7.8% 3,213,226 -2.1% 6.4% $11,246,291
ROYCE & ASSOCIATES LP 5.9% 2,443,035 -1.3% 0.09% $8,550,623
VANGUARD GROUP INC 3.8% 1,565,078 +2.4% 0% $5,477,774
AIGH Capital Management LLC 2.7% 1,104,970 1.1% $3,867,395
Silverberg Bernstein Capital Management LLC 2.5% 1,033,003 +4.7% 2.1% $3,615,511
COMMONWEALTH EQUITY SERVICES, LLC 1.6% 663,541 0% 0% $2,322,390
HORIZON KINETICS ASSET MANAGEMENT LLC 1.5% 615,000 0% 0.03% $2,152,500
BlackRock, Inc. 1.2% 510,980 +0.24% 0% $1,788,432
Taylor Frigon Capital Management LLC 1.1% 437,961 -6.9% 0.78% $1,532,864
GEODE CAPITAL MANAGEMENT, LLC 0.87% 358,829 +2.1% 0% $1,256,736
Informed Momentum Co LLC 0.6% 246,435 0.1% $862,523
Huntleigh Advisors, Inc. 0.57% 236,398 0.14% $827,417
RENAISSANCE TECHNOLOGIES LLC 0.54% 220,395 -0.59% 0% $771,383
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.49% 201,651 0% $705,779
Kingsview Wealth Management, LLC 0.46% 188,193 -2.5% 0.01% $658,676
JANE STREET GROUP, LLC 0.41% 168,238 0% $588,834
Caption Management, LLC 0.39% 160,407 +29% 0.02% $561,425
SEI INVESTMENTS CO 0.36% 150,081 0% $525,284
683 Capital Management, LLC 0.3% 124,506 0.04% $435,771
STATE STREET CORP 0.28% 116,706 +6.8% 0% $408,471
MARSHALL WACE, LLP 0.26% 107,875 0% $377,565
NORTHERN TRUST CORP 0.26% 105,638 -1.1% 0% $369,734
Hillsdale Investment Management Inc. 0.23% 94,500 0.01% $330,750
Qube Research & Technologies Ltd 0.23% 93,679 0% $327,877

Institutional Holders of Apyx Medical Corp - Common Stock (APYX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 19,029,797 $66,600,441 +$11,936,562 $3.50 58
2025 Q3 15,737,051 $33,674,427 -$213,867 $2.14 47
2025 Q2 15,811,115 $35,574,319 +$288,225 $2.25 39
2025 Q1 15,792,917 $21,635,134 -$202,681 $1.37 43
2024 Q4 15,925,107 $25,160,336 +$4,988,209 $1.58 45
2024 Q3 12,800,031 $15,871,504 -$371,477 $1.24 45
2024 Q2 13,089,462 $17,538,939 -$313,631 $1.34 49
2024 Q1 13,334,937 $18,134,845 -$10,597,896 $1.36 51
2023 Q4 17,452,702 $45,730,029 -$5,190,379 $2.62 62
2023 Q3 18,328,200 $58,651,537 -$229,028 $3.20 61
2023 Q2 18,770,221 $94,412,555 -$2,505,631 $5.03 55
2023 Q1 20,085,109 $58,156,535 +$5,918,433 $2.88 54
2022 Q4 18,191,340 $42,568,844 -$7,872,047 $2.34 48
2022 Q3 20,926,665 $93,963,141 -$1,016,635 $4.49 53
2022 Q2 21,031,854 $123,244,150 +$8,066,381 $5.86 61
2022 Q1 19,582,685 $127,931,812 -$1,520,009 $6.53 70
2021 Q4 19,106,864 $244,910,256 -$2,633,464 $12.82 74
2021 Q3 18,881,855 $261,278,213 +$1,837,936 $13.85 74
2021 Q2 19,074,530 $196,570,403 +$519,685 $10.31 73
2021 Q1 18,975,246 $183,295,913 +$4,233,889 $9.66 67
2020 Q4 18,563,287 $133,715,214 +$4,919,670 $7.20 63
2020 Q3 17,818,092 $83,924,627 -$799,192 $4.71 59
2020 Q2 18,132,429 $100,699,990 +$1,987,743 $5.55 60
2020 Q1 17,698,113 $63,538,783 -$3,782,110 $3.59 64
2019 Q4 18,252,816 $154,427,344 +$472,016 $8.46 68
2019 Q3 17,769,394 $120,273,837 +$8,067,427 $6.77 67
2019 Q2 17,318,462 $116,360,053 +$14,336,984 $6.72 66
2019 Q1 15,330,673 $96,737,645 +$87,019,958 $6.31 77
2018 Q4 924,973 $5,994,000 +$5,994,000 $6.48 2